Drug discovery: schistosome treatment.
Shadan
Sadaf
S
D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D000975:Antioxidants / Q000378:metabolism; D002460:Cell Line; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D006801:Humans; D051379:Mice; D010069:Oxadiazoles / Q000494:pharmacology* / Q000633:toxicity; D011223:Praziquantel / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D012550:Schistosoma mansoni / Q000187:drug effects / Q000378:metabolism; D012552:Schistosomiasis / Q000188:drug therapy* / Q000469:parasitology*
C528141:1,2,5-oxadiazole 2-oxide; D000871:Anthelmintics; D000975:Antioxidants; D010069:Oxadiazoles; D011223:Praziquantel